Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation: 24/09/2020, Revision: 11, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 9 January 2026 - 14:12

Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation: 24/09/2020, Revision: 11, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ayvakyt

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters